Israel’s NeuraLight has partnered with New York’s CHDI Foundation to build one of the largest eye movement datasets for Huntington’s Disease. It will support CHDI’s work to develop sensitive, trial-ready tools with the potential to develop HD therapies.

https://neuralight.ai/neuralight-and-chdi-foundation-collaborate-to-develop-precision-eye-movement-biomarkers-for-huntingtons-disease/